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If a  humoral pressor substance is responsible for essential hypertension in 
man, one of its characteristics should be the ability to constrict the arteriolar 
bed sufficiently to increase total systemic peripheral resistance, but not suffi- 
ciently to reduce cutaneous blood flow.  Clinical experience indicates that pa- 
tients with essential hypertension do  not have  cold,  pale  skin reflecting di- 
minished blood flow. More objective studies of total systemic peripheral blood 
flow in persons with essential hypertension have demonstrated no significant 
reduction from normal levels (1, 2). 
This  hypothetical pressor  substance  should  also  be  capable  of producing 
generalized systemic arteriolar constriction without inducing significant con- 
striction or decreased blood flow in a cutaneous capillary bed such as the nail- 
fold.  Studies of  the  nailfold  capillary  bed  in persons with  essential  hyper- 
tension have indicated the  absence  of  significant  capillary  constriction  or 
decreased  capillary  blood  flow (3, 4). 
Two naturally occurring pressor agents, norepinephrine and angiotonin, when 
infused  intravenously  into  persons  with  normal  blood  pressure,  produce 
changes in the central systemic circulation similar to those found in persons 
with essential hypertension (5, 6). The hypertensive state associated with the 
infusion of norepinephrine  however differs  markedly from  essential  hyper- 
tension when the circulation in a cutaneous capillary bed such as the nailfold 
is  examined.  L-Norepinephrine  induces  a  progressive  constriction  of  this 
capillary bed as the rate of infusion is increased, so that the nailfold capillary 
bed is rendered ischemic prior to attainment of hypertensive diastolic arterial 
blood pressure levels (4). 
The purpose of the present study was to determine the reaction of a cutaneous 
capillary bed in persons made hypertensive by the infusion of angiotonin and to 
compare this reaction with that seen in persons with hypertension induced by 
L-norepinephrine and in persons with essential hypertension. The vascular bed 
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of  the  nailfold  of  the  finger  was  selected  for  observation  since  the  capillary 
loops can be visualized readily for prolonged periods without discomfort to the 
patient.  The  nail/old  observations  indicate  that  angiotonin,  unlike  L-norepi- 
nephrine,  is  capable  of  elevating  systemic  arterial  blood  pressure  without 
inducing ischemia of this segment of the cutaneous capillary bed. Evidence was 
also  obtained  that  the  nailfold  capillary  bed  of  persons  made  hypertensive 
by the intravenous  infusion of angiotonin exhibited a  hyperreactivity to circu- 
lating L-norepinephrine similar to that found in patients  with essential hyper- 
tension. 
Metkod 
Eleven hospitalized patients with no evidence of cardiovascular disease,  and one patient 
with generalized arteriosclerosis were studied.  No patient was receiving medication known 
to produce  cardiovascular changes.  During  the observations the  subjects were recumbent 
with two blankets over the trunk and lower extremities. Studies were not performed until 
the fingers had become warm to the touch. One arm was then abducted approximately 30  ° 
from the side, with the terminal phalanx of the fourth finger at the level of the sternum. 
Cedar oil was applied to the base of the nail bed and the finger steadied by a clamp applied 
along the lateral margins of the phalanx. The terminal capillary loops could thus be readily 
visualized microscopically when illuminated by a slit lamp. A blood pressure cuff was placed 
about the opposite arm and an infusion of physiologic saline begun in the antecubital vein 
in such a manner as not to interfere with auscultatory blood pressure determinations. Follow- 
ing these procedures, 20 minutes or longer were allowed to elapse until  the blood  pressure 
had stabilized. If at the end of this period the fingers  had become cool,  pale, or cyanotic, 
or if the blood flow  through  the capillary loops had  slowed  as  visualized microscopically, 
another 20 minutes were allowed to elapse.  If the fingers did not become warm and capillary 
blood flow did not stabilize at a uniform and rapid rate, no further observations were made. 
After the control period, a solution of L-norepinephrine,  1 4 V/cc.j or a 4 per cent angiotonin  2 
solution in physiologic saline was then substituted for the original saline solution by changing 
the infusion bottle without disturbing the patient. The rates of the L-norepinephrine or the 
angiotonin infusions were increased progressively by increments of 10 to 50 per cent at  5 
to 15 minutes intervals. With each increment the arterial blood pressure, the pulse rate and 
the reaction of the terminal capillary loops at the base of the fingernail were recorded. In 
eight patients,  the reaction  to  the  intravenous  infusion  of L-norepinephrine  was  studied 
initially, followed 5 to 15 days later by a similar study of the reaction of the same capillary 
bed to the intravenous infusion of angiotonin.  In three  patients,  only the reaction to the 
intravenous infusion of angiotonin was observed. One patient (patient 9) received an initial 
infusion of angiotonin, followed 15  minutes  after discontinuance  by a L-norepinephrine  in- 
fusion. 
The minimal quantity of T.-norepinephrine  required to initiate a  15 second nailfold capil- 
lary constriction, administered as a single rapid intravenous injection, was determined prior 
to and  during  the administration  of the angiotonin infusions.  The method  for  the  deter- 
mination of this "threshold capillary reactivity" has been described previously (3). 
Alterations of nailfold capillary diameter and  blood  flow  were also  observed  following 
the abrupt discontinuation of the infusions of L-norepinephrine or angiotonin. 
1 Bitartrate salt (synthetic: supplied by Winthrop-Stearns, Inc.). 
2 Supplied by O. M. Helmerj Lilly Laboratory for Clinical Research. SHELDON  E.  GP~EISM~AN  479 
RESULTS 
The effects of the infusion of L-norepinephrine  and of angiotonin on blood 
pressure, pulse rate, and the capillary bed of the na~old are outlined in Table 
I.  Prior  to the infusion of ang~otonin  or L-norepinephrine,  intermittent  and 
irregular gaps in blood flow were seen in the arterial segments of the terminal 
capillary loops.  These gaps in capillary blood flow rarely exceeded 2 seconds 
in duration.  The infusion of L-norepinephrine  in patients with normal blood 
pressure produced a  progressive increase in the frequency, and subsequently 
the duration  of these periodic gaps in capillary blood flow, until  a  state of 
sustained  ischemia  developed,  characterized  by the  "disappearance"  of in- 
creasing  numbers  of capillary  loops and  by slowing  and  stagnation  of red 
blood cells in other vessels.  As it was usually impossible  to visualize  the ar- 
terial  system proximal  to  the  terminal  capillary loops,  it  could not  be as- 
certained whether the normally occurring  gaps in capillary blood flow and  the 
ischemia  induced by the infusion  of L-norepinephrine  were due to constriction 
of the arterial segments of the capillary loops or to constriction of the parent 
arterioles.  An initial ischemic  reaction, whereby in a field of fifteen to twenty 
vessels, two or more capillary loops were rendered invisible,  occurred when the 
T.-norepinephrine  infusion  had elevated the  diastolic blood pressure  6  to  24 
ram. Hg (average 16 mm. Hg) above the initial levels. Capillary ischemia  thus 
usually appeared prior to the development of hypertensive diastolic arterial 
blood pressure levels. 
The infusion  of angiotonin,  like the infusion  of L-norepinephrine,  produced 
a rise in systolic, diastolic,  and mean arterial pressure. As the rate of infusion 
of angiotonin was increased,  the frequency of the intermittent  gaps in capil- 
lary  blood  flow  increased,  although  four  of  the  twelve  patients  exhibited 
minimal changes,  Table I. The duration of these gaps in blood flow, however, 
did not increase  so that even at the highest rates of angiotonin infusion,  with 
elevation of diastolic blood pressure levels to 90 mm. Hg or above, the capil- 
lary loops exhibited no evidence of sustained ischemia.  "Disappearance"  of 
terminal  capillary loops and  slowing  or  stagnation  of clumps  of red blood 
cells  in  the  vascular  lumen,  as  occurred  during  T.-norepinephrine  infusions, 
was not  seen during  angiotonin  infusions.  One  exception  was noted  in  the 
patient  with  diabetes  mellitus  recovering  from  exogenous  protamine  zinc 
hyperinsulinism. 
Prior to the angiotonin infusions,  the "threshold capillary reactivity" to a 
single  rapid  intravenous  injection  of T.-norepinephrine  fell  between  1.5  and 
2.5 7. During the infusion of angiotonin, a significant  decrease in the threshold 
capillary  reactivity to  L-norepinephrine  developed,  so that  0.5  to  1.0  "r  of 
L-norepinephrine  produced  similar  vasoconstrictor  effects,  Table  I.  This 
reactivity is similar to that reported for persons with essential hypertension (3). 
Following the abrupt discontinuance  of the L-norepinephrine  infusion,  the TABLE  I 
The Effect  of the Infusion of 0.0004 per Cent ~Norepinephrine and of 4 per Cent Angiotonin 
upon the Blood Pressure  Pulse Ra~e, and Capillary  Bed of the Nailfold 
Rate of infusion  of 
norepinephrine or angiotonin 
Arterial 
blood 
pressure 
Pulse  Intermittency 
rate (per  of capillary  Duration of 
minute)  blood flow*  infusion 
Threshold 
eapillary 
reactivity, to 
L-norem- 
nephrme 
Duration 
of effect 
ram. Hg  mi~.  7  sec. 
Patient 1, age 27  Diagnosis: No organic disease 
A.  L-norepinephrine 
"y  / hg. rain. 
0.04 
0.08 
0.12 
0.31 
0.44 
B. Angiotonin 
cc./kg, rain. 
0.10 
0.14 
lOO/58 
106/66 
112/74 
12o/8o 
126/82 
180/96 
lOO/58 
130/80 
150/90 
72 
72 
70 
68 
68 
52 
72 
68 
60 
2X 
2X 
2X 
3X 
Ischemia 
2X 
2X 
2X 
15 
15 
15 
15 
15 
15 
1.5 
0.5 
15 
15 
Patient 2, age 43  Diagnosis:  Chronic Alcoholism 
A.  L-norepinephrine 
7 /kg. rain. 
0.06 
0.09 
0.11 
0.18 
B.  Angiotonin 
cc./kg, rain. 
0.05 
0.07 
0.08 
110/68 
116/70 
132/76 
160/82 
190/90 
118/80 
126/88 
140/100 
168/108 
72 
72 
60 
56 
48 
72 
72 
60 
60 
2X 
2X 
3X 
3X 
Ischemia 
3X 
3X 
3X 
3X 
10 
10 
15 
I0 
10 
15 
15 
1.5  25 
O. 75  20 
Patient 3, age 51  Diagnosis: Pernicious anemia in remission 
A.  L-norepinephrine 
7/kg. min. 
0.16 
0.25 
B.  Angiotonin 
cc./kg, rain. 
0.06 
0.11 
0.13 
0.15 
100/64 
120/70 
146/80 
11o/68 
120/73 
128/8o 
144/86 
152/88 
74 
63 
63 
76 
74 
66 
66 
66 
X 
Ischemia  15 
15 
5 
10 
10 
15 
1.5 
1.0 
15 
25 
* Average number of gaps in blood flow  through the arterial segments of  the nailfold 
capillary loops per minute, x  =  3-8; 1 X  --  9-14; 2 X  =  15-25; 3  X  --- 25-30. 
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Rate of infusion  of 
noreplnephrine  or angiotonln 
Arterial 
blood 
pressure 
Pulse  Intermitteucy 
rate (per  of capillary 
minute)  blood flow* 
Duration of 
infusion 
Threshold 
capillary  ! 
reactivity, to 
I,~nore~l- 
nephrme 
Duration 
of effect 
ram.  Hg  rain.  7  sec. 
Patient 4, age 65  Diagnosis: Gastric carcinoma 
A.  L-norepinephfine 
"y  / kg. min. 
0.14 
0.24 
0.32 
0.38 
B.  Angiotonin 
cc.lkg, rain. 
0.05 
0.10 
0.16 
0.22 
110/52 
120/56 
120/60 
140/66 
150170 
13o/58 
140/62 
146/68 
150/70 
156/94 
92 
90 
84 
81 
81 
92 
92 
92 
92 
84 
2X 
2X 
3X 
Ischemia 
~c 
1X 
1X 
2X 
2X 
2X 
15 
15 
15 
10 
15 
15 
10 
10 
1.5  20 
O. 75  20 
Patient 5, age 38  Diagnosis:  Resolved acute pyelonephritis 
A. r.-norepinephrine 
"r  /kg. rain. 
0.11 
0.16 
0.24 
B.  Angiotonin 
cc.l~g, rain. 
0.08 
0.11 
0.13 
94•52 
98/58 
104164 
130/76 
90/54 
94/64 
110/74 
120/76 
68 
60 
60 
54 
52 
45 
45 
42 
1X 
2X 
2X 
Ischemia 
X 
1X 
1X 
1X 
10 
10 
10 
15 
15 
15 
2.0 
0.5 
15 
10 
Patient 6, age 53  Diagnosis:  Carcinoma of the breast 
A.  L-norepinephrine 
7/kg. min. 
0.06 
0.10 
0.16 
0.20 
0.28 
B.  Angiotonin 
ce./kg, rain. 
0.04 
0.05 
0.08 
0.11 
126/74 
128/76 
13o/8o 
144/80 
152/80 
170/80 
116/64 
116/74 
120174 
120/80 
150/86 
88 
88 
81 
72 
68 
60 
78 
78 
78 
75 
72 
1X 
1X 
3X 
3X 
Ischemia 
cc 
1X 
2X 
2X 
2X 
2X 
10 
10 
15 
15 
15 
15 
15 
15 
15 
2.5  10 
0.75  20 
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Rate of infusion of 
norepinephrine or angiotonin 
Arterial 
blood 
pressure 
Pulse  Intermittency 
rate  (per  of capillary 
minute)  blood flow* 
Duration  of 
infusion 
Threshold  [ 
capillary  [ 
reactivity to I 
L-norepi- 
nephrine 
Duration 
of effect 
ram.  Hg  mln.  ~t  sec. 
Patient 7, age 51  Diagnosis: Postencepkalitic paralysis agitans 
A. L-norepinephrine 
"y  /kg. rain. 
0.14 
0.23 
0.32 
B.  Angiotonin 
cc./kg, rain. 
0.07 
0.11 
0.14 
104/66 
122/74 
163/80 
180/86 
120/68 
134/76 
146/80 
150/88 
72 
66 
63 
63 
72 
72 
72 
72 
1× 
3X 
Ischemia 
1X 
1× 
1× 
1X 
1 
10 
10 
5 
10 
10 
15 
2.0  10 
O. 75  10 
Patient 8, age 78  Diagnosis: Generalized atherosclerosis 
A. L-norepinephrine 
•  r/kg. rain. 
0.04 
0.10 
0.20 
0.32 
B. Angiotonin 
cc./  kg. rain. 
0.08 
0.12 
0.24 
150/54 
152/56 
170/60 
200/68 
226/70 
120/58 
158/64 
164/7o 
190/108 
76 
76 
76 
74 
70 
72 
72 
72 
72 
1X 
1X 
2X 
3× 
Ischemia 
X 
1X 
1X 
2X 
5 
5 
5 
10 
10 
10 
25 
2.0  25 
0.5  20 
A. Angiotonin 
cc./kg, rain. 
0.07 
0.12 
0.16 
0.18 
B. L-norepinephrine 
~/kg. rain. 
0.07 
0.24 
Patient 9, age 61  Dia  'nosis: Chronic alcoholism 
140/80 
160/84 
180/90 
196/94 
200/100 
140/74 
154/80 
190/90 
72 
70 
70 
68 
64 
72 
7O 
6O 
1× 
1  X  10 
1  X  15 
2  X  15 
2  X  10 
Ischemia  10 
"  15 
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Rate of infusion  of 
norepinephrine or anglotonin  pressure 
Pulse 
rate (per 
minute)  blood flow* 
Duration of 
infusion 
Threshold 
capillary 
reactivity, to 
L-norept- 
nephrine 
Duration 
of effect 
ram. Hg  mln.  ~  sea, 
Patient 10, age 42  Diagnosis: Anorexia nervosa 
A. Angiotonin 
cc./kg, min. 
0.09 
0.13 
0.27 
110/70 
14o/84 
160/90 
17O/lOO 
100 
100 
100 
90 
X 
X 
2X 
2X 
10 
15 
15 
2.0 
0.5  20 
Patient 11, age 42  Diagnosis: Chronic, alcoholism 
A. Angiotonin 
cc./kg, min. 
0.09 
0.12 
0.15 
104/74 
112/80 
120/88 
130/98 
76 
70 
X 
2X 
2X 
2X 
m 
10 
20 
30 
1.5  30 
O. 75  30 
Patient 12, age 76  Diagnosis: Diabetes mellitus; exogenous hyperinsulinism 
A. Angiotonin 
cc./kg, rain. 
0.10 
0.14 
14o/6o 
180/86 
200/90 
72 
72 
72 
2X 
2X 
Ischemia 
15 
15 
1.5 
0.5 
20 
25 
naflfold capillary bed dilated gradually in six of the  eight patients  studied, 
becoming hyperemic within 3  to 8  minutes with a  concomittant cessation of 
the  intermittent  gaps  in  capillary  blood flow.  A  cutaneous  flush  over  the 
forearms and face was  often noted at  this  time.  Capillary dilatation,  inter° 
mittency  of  capillary  blood  flow,  and  the  cutaneous  flush  then  gradually 
returned to the initial state, usually within 5 to 10 minutes after the onset of 
hyperemia. In contrast, in all subjects studied with the exception of the pa- 
tient  recovering from  exogenous hyperinsulinism,  the  capillary  bed  of  the 
nailfold returned directly to the original state following the abrupt cessation of 
the infusion of angiotonin. No cutaneous flush was seen. 
Fig.  1 is a photomicrograph (X  114)  of the capillary bed of the nailfold of 
a patient with a diastolic arterial blood pressure of 54 mm. Hg. Fig. 2 indicates 
the ischemic reaction produced during the  intravenous infusion of L-norepi- 484  HYPERTENSION  AND  ANGIOTONIN  AND  L-NOltEPINEPHRII~E 
nephrine when the diastolic blood pressure had been elevated to 80 mm. Hg. 
Fig. 3 depicts the same capillary bed during the intravenous infusion of angio- 
tonin 5  days later,  when the initial diastolic blood pressure  of 60  mm. Hg. 
had been elevated to 90 mm Hg. There is no evidence of capillary ischemia. 
DISCUSSION 
Previous  investigators have  indicated  that  pressor  agents  which  severely 
reduce cutaneous blood flow in relation to their ability to raise arterial blood 
pressure could scarcely be expected to be concerned in the genesis of essential 
hypertension  (7).  A  central  systemic  hemodynamic  state  resembling  that 
found in patients with essential hypertension can be produced in persons with 
normal blood pressure  by the  infusion of either of  two naturally occurring 
substances, L-norepinephrine or angiotonin. However when L-norepinephrine 
was infused in persons with normal blood pressure,  ischemia of a  cutaneous 
capillary--that of the nailfold---developed prior to the attainment of hyper- 
tensive blood pressure levels. Such nailfold capillary ischemia was not seen in 
persons with essential hypertension, even during the malignant phase of the 
hypertensive disease (3). These findings parallel the changes in over-all blood 
flow to the extremities as evidenced by the reduction in forearm blood flow 
and the markedly decreased heat elimination from the hand during norepi- 
nephrine induced hypertension (8), in contrast to the relatively normal periph- 
eral blood flow and heat elimination found in persons with essential hyper- 
tension (1, 2, 6). 
Since  reactive  hyperemia indicates  the  prior  existence  of  tissue  ischemia 
(9),  the frequent occurrence of cutaneous flushing and the reactive hyperemia 
seen in the nailfold capillary bed following the abrupt discontinuance of the 
L-norepinephrine infusion is further evidence that norepinephrine significantly 
curtails skin blood flow. Transient reactive hyperemia following depression of 
forearm  blood  flow  has  previously  been  reported  after  discontinuation  of 
noradrenaline infusions (8). 
Angiotonin differed from L-norepinephrine by raising systemic arterial blood 
pressure without inducing a  sustained ischemia of the nailfold capillary bed. 
The  one exception, noted in  the  patient recovering from exogenous hyper- 
insulinism,  may be  attributable  to  an  increase  in  endogenous  epinephrine 
secretion that is known to occur in  this state  (10).  The absence of nailfold 
capillary hyperemia after  the  abrupt  cessation  of  the  angiotonin infusions 
yielded  corroborative  evidence  of  the  maintainence  of  adequate  capillary 
blood flow. Previous objective evidence for normal cutaneous blood flow dur- 
ing angiotonin infusions in man was based upon the absence of a  significant 
reduction of skin temperature (6). 
The effects of L-norepinephrine and angiotonin on nailfold capillary blood 
flow in man are comparable to those produced in the peripheral circulation in SIKELDON  E.  GREISMAN  485 
animals.  Elevation of arteriaYblood pressure of rabbits with angiotonin, renin, 
or induced renal hypertension was associated with visible arteriolar constric- 
tion  in  the  ear  and  mesentery,  but in  contrast  to  epinephrine  and  norepi- 
nephrine,  capillary  blood  flow  and  capillary  diameter  were  not  decreased 
(11-14).  In addition,  skin temperature  was not reduced significantly  during 
injections of renal extracts which elevated arterial blood pressure, renin thus 
being  unique  among  all  other  pressor  substances  (7).  Furthermore,  when 
renin was injected into rabbits with preexisting renal hypertension, the arterial 
blood pressure  was markedly  elevated  without  a  concomitant  decrease  in 
skin temperature (15). Dogs also failed to exhibit a consistent change in skin 
temperature during angiotonin infusions  (16). 
The absence of sustained nail/old capillary ischemia,  despite the increased 
frequency of interruptions in capillary blood flow which usually characterized 
the  angiotonin  induced  hypertension,  has  often been noted in  persons with 
essential  hypertension  (3,  4).  By direct  microscopic observations,  therefore, 
the  nail/old  capillary  bed  in  persons  with  angiotonin-induced  hypertension 
could not be distinguished  from  that  seen in  persons  with  essential  hyper- 
tension.  One rather  characteristic  alteration  of the nail/old  capillary vessels 
in subjects with essential  hypertension,  in  contrast  to subjects with normal 
blood  pressure,  is  the  hyperreactivity  exhibited  to  intravenously  injected 
L-norepinephrine  (3, 4). The L-norepinephrine  reactivity of the nail/old capil- 
lary bed was therefore evaluated in  the present group of normotensive sub- 
jects  prior  to  and  during  the  angiotonin-induced  hypertension.  Significant 
capillary hyperreactivity to norepinephrine  was found to develop during  the 
infusion of angiotonin, so that the nailfold  vessels in persons with angiotonin- 
induced  hypertension  remained  indistinguishable  from  that  of persons with 
essential hypertension. Thus from the standpoint of its effects upon the nailfold 
capillary  bed,  angiotonin,  unlike  L-norepinephrine,  is  one  substance  which 
possesses  the  properties  required  of  the  hypothetical  humoral  pressor  sub- 
stance of essential  hypertension. 
CONCLUSIONS 
Further evidence has been obtained that L-norepinephrine  infusions markedly 
decreases cutaneous capillary blood flow in  the nail/old.  Sustained  ischemia 
of the capillary bed occurred prior to the attainment of hypertensive diastolic 
arterial blood pressure levels.  Corroborative evidence of this nailfold  capillary 
ischemia  was obtained from  the  capillary  reactive  hyperemia  that  followed 
the abrupt discontinuance of the L-norepinephrine  infusions. 
The infusion of angiotonin into persons with normal blood pressure did not 
induce sustained ischemia  of the nailfold  capillary vessels,  even after definite 
hypertensive diastolic arterial blood pressure levels were attained.  Corrobora- 
tion of the adequacy of nailfold  capillary blood flow was obtained by noting 486  IIYPERTENSION  AND  ANGIOTONIN  AND  L-NOREPINEPIIRINE 
the  absence  of capillary reactive  hyperemia foIlowing the  abrupt  cessation 
of the angiotonln infusions. 
The nailfold capillary bed in persons with angiotonin-induced hypertension 
could not be distinguished from that of persons with essential hypertension 
by direct microscopic examination. 
During the infusion of angiotonin into subjects with normal cardiovascular 
systems, the reactivity of the nailfold capillary bed to circulating L-norepi- 
nephrine was significantly increased, approaching the levels found in persons 
with essential hypertension. 
From the standpoint of its effects upon the nailfold capillary bed, angio- 
tonin, unlike T.-norepinephrine,  is one substance which possesses  the proper- 
ties required of the hypothetical humoral pressor substance of essential hyper- 
tension. 
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EXPLANATION OF PLATE 20 
FIG.  1.  Capillary  bed  of the nailfold of a  patient with normal blood pressure. 
Blood pressure  =  100/54. Pulse rate =  74. ×  114. 
FIG. 2. Ischemic reaction  of the capillary bed during T.-norepinephrine infusion, 
0.25 gamma/kg, min. Blood pressure  =  146/80. Pulse rate  =  63. 30 minutes after 
start of infusion. ×  114. 
Fro. 3. Absence of ischemia of the capillary bed during angiotonin infusion, 0.15 
cc./kg, mill. Blood pressure  =  152/90. Pulse rate  =  66. (40 minutes after start of 
infusion). ×  114. THE  JOURNAL OF EXPERIMENTAL  MEDICINE VOL. 103  PLATE 20 
(Greisman: Hypertension and angiotonin and L-norepinephrine) 